Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Updated on: March 01,2024

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Updated on:March 01,2024

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on: January 30,2024

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same

Updated on:January 30,2024

Research team discovers a connection between nutrients and follicular lymphoma

by The Spanish National Cancer Research CentreOn the left, follicular lymphoma in a mouse model with abundant multiplying B cells dyed brown. On the right, inhibition of this multiplication using

Updated on: May 27,2024

Research team discovers a connection between nutrients and follicular lymphoma

by The Spanish National Cancer Research CentreOn the left, follicular lymphoma in a mouse model with abundant multiplying B cells dyed brown. On the right, inhibition of this multiplication using

Updated on:May 27,2024

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on: March 24,2024

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on:March 24,2024

Young age associated with worse prognosis in specific breast cancer subtype

by Johns Hopkins University School of MedicineResearcher in lab. Credit: Johns Hopkins Kimmel Cancer CenterResearchers at Johns Hopkins Kimmel Cancer Center are rapidly advancing the understandin

Updated on: April 22,2024

Young age associated with worse prognosis in specific breast cancer subtype

by Johns Hopkins University School of MedicineResearcher in lab. Credit: Johns Hopkins Kimmel Cancer CenterResearchers at Johns Hopkins Kimmel Cancer Center are rapidly advancing the understandin

Updated on:April 22,2024

Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up

by Children's Hospital BostonExtracellular vesicles, also known as exosomes, cross the blood-brain barrier via a transcytosis process. Credit: Kristin Johnson/Vascular Biology Program, Boston

Updated on: May 31,2024

Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up

by Children's Hospital BostonExtracellular vesicles, also known as exosomes, cross the blood-brain barrier via a transcytosis process. Credit: Kristin Johnson/Vascular Biology Program, Boston

Updated on:May 31,2024

Researchers move closer to 'magic' cancer treatment

by Brent Wittmeier,University of AlbertaU of A researcher Khaled Barakat with the IBM supercomputer his team used to develop a small molecule that could help the body fight cancer by allowing th

Updated on: June 15,2024

Researchers move closer to 'magic' cancer treatment

by Brent Wittmeier,University of AlbertaU of A researcher Khaled Barakat with the IBM supercomputer his team used to develop a small molecule that could help the body fight cancer by allowing th

Updated on:June 15,2024

Study reveals a trio of immune cells vital in response to liver cancer immunotherapy

by The Mount Sinai HospitalThe study revealed how certain immune cell interactions in tumors facilitate response to checkpoint blockade, pointing to potential new approaches to cancer immunothera

Updated on: February 23,2024

Study reveals a trio of immune cells vital in response to liver cancer immunotherapy

by The Mount Sinai HospitalThe study revealed how certain immune cell interactions in tumors facilitate response to checkpoint blockade, pointing to potential new approaches to cancer immunothera

Updated on:February 23,2024

The right moves: How studying cell movement during embryonic development may offer new insights into cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterUnder the microscope, MSK scientists studied how cells in a mouse embryo (green) move out and break away from their original tissue by contrac

Updated on: February 23,2024

The right moves: How studying cell movement during embryonic development may offer new insights into cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterUnder the microscope, MSK scientists studied how cells in a mouse embryo (green) move out and break away from their original tissue by contrac

Updated on:February 23,2024

Being a 'morning person' linked to lower risk of breast cancer

by British Medical JournalCredit: CC0 Public DomainBeing a morning person (popularly known as larks) is associated with a lower risk of developing breast cancer than being an evening person (popu

Updated on: March 21,2024

Being a 'morning person' linked to lower risk of breast cancer

by British Medical JournalCredit: CC0 Public DomainBeing a morning person (popularly known as larks) is associated with a lower risk of developing breast cancer than being an evening person (popu

Updated on:March 21,2024

Crucial role of JUN protein in restraining liver cancer growth discovered

by Leibniz Institute on Aging – Fritz Lipmann Institute (FLI)Synopsis. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-024-00188-0A team of scientists led by Dr. Björn von Eyss has disc

Updated on: September 07,2024

Crucial role of JUN protein in restraining liver cancer growth discovered

by Leibniz Institute on Aging – Fritz Lipmann Institute (FLI)Synopsis. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-024-00188-0A team of scientists led by Dr. Björn von Eyss has disc

Updated on:September 07,2024

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is

Updated on: March 01,2024

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is

Updated on:March 01,2024